
241.53 Delayed Data As of Dec 08 | ![]() Today’s Change | 204.44 Today|||52-Week Range 283.09 | -13.15% Year-to-Date |
Insider Sell Alert: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United ... Dec 08 / GuruFocus News - Paid Partner Content | United Therapeutics (UTHR) Up 5.2% Since Last Earnings Report: Can It Continue? Dec 01 / Zacks.com - Paid Partner Content |
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue? Dec 07 / Zacks.com - Paid Partner Content |
Previous close | 242.07 |
Today’s open | 242.64 |
Day’s range | 240.09 - 244.09 |
Volume | 12,579 |
Average volume (3 months) | 286,910 |
Market cap | $11.3B |
Earnings growth (last year) | +50.84% |
Earnings growth (this year) | +24.96% |
Earnings growth (next 5 years) | +0.67% |
Revenue growth (last year) | +14.88% |
P/E ratio | 13.3 |
Price/Sales | 6.97 |
Price/Book | 2.31 |
Next reporting date | February 21, 2024 |
EPS forecast (this quarter) | $4.33 |
Annual revenue (last year) | $1.9B |
Annual profit (last year) | $727.3M |
Net profit margin | 37.56% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Silver Spring, Maryland |